Keyphrases
Adaptive Immune Response
18%
Adjuvant Therapy
20%
Allergic Airway Inflammation
17%
Asthma
26%
Asthma Control
34%
Asthma Management
26%
Asthma Patients
47%
Asthma-chronic Obstructive Pulmonary Disease Overlap Syndrome
17%
Bronchial Hyperresponsiveness
17%
Bronchiolar
17%
CD11b+
17%
CD11c+ Cells
17%
Cement Dust Exposure
17%
Chest X-ray
19%
Chronic Obstructive Pulmonary Disease
100%
Coliforms
17%
COVID-19
71%
COVID-19 Pandemic
34%
COVID-19 Patients
20%
Emphysema
17%
Forced Expiratory Volume in 1 Second (FEV1)
51%
Forced Vital Capacity
46%
Heavy Metal Assessment
17%
Human Umbilical Cord Mesenchymal Stromal Cells
17%
Immunopathogenesis
17%
Indonesia
50%
Indonesian Patients
34%
Jakarta
21%
Lung
22%
Lung Function
83%
Lung Function Parameters
17%
Lung Hyperinflation
17%
Lung Inflammation
17%
Mesenchymal Stem Cells
45%
NKT Cells
17%
Nuclear Factor Erythroid 2-related Factor 2 (Nrf2)
17%
Observational Survey
17%
OX40
17%
Pathophysiology
19%
Patient Characteristics
17%
Persistent Asthma
21%
Randomized Controlled Trial
34%
Regular Air
17%
Respirator
17%
Respiratory Symptoms
40%
Safety Profile
21%
Spirometry
23%
Syndecan-4
17%
Toll-like Receptor 9 (TLR9)
17%
Vietnam
21%
Medicine and Dentistry
3-Amino-1,2,4-triazole
8%
Adjuvant Therapy
20%
Allergic Rhinitis
17%
Asthma
79%
Asthma Exacerbation
17%
Breathing
17%
Bronchodilating Agent
9%
Chronic Obstructive Pulmonary Disease
72%
Coronavirinae
17%
COVID-19
69%
Cross Sectional Study
44%
Degenerative Disease
6%
Diaphragm
17%
Diseases
36%
Echography
11%
Edema
8%
Emphysema
17%
Fenofibrate
8%
Forced Expiratory Volume
31%
Forced Vital Capacity
48%
Gastroesophageal Reflux
17%
Heart Muscle Injury
17%
Hyperbarism
17%
Infusion
6%
Intensive Care Unit
6%
Lung
51%
Lung Function
17%
Mental Health
17%
Mesenchymal Stem Cell
52%
N-Acetylprocainamide
8%
Overlap Syndrome
17%
Paranasal Sinus
8%
Pathophysiology
17%
Patient Characteristics
17%
Patient Referral
8%
Patient with Asthma
18%
Prevalence
18%
Prick Test
8%
Primary Health Care
8%
Randomized Controlled Trial
17%
Secretory Leukocyte Protease Inhibitor
9%
Sinusitis
8%
Spirometry
22%
Stem Cell
10%
Supplementation
17%
Survival Rate
7%
Syndecan 4
17%
Thin-Layer Chromatography
7%
Transcription Factor Nrf2
17%
Umbilical Cord
17%
